Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2016) 5 P462 | DOI: 10.1530/boneabs.5.P462

Other diseases of bone and mineral metabolism

Secondary bone size deficit in patients with Ehlers–Danlos syndrome

Charlotte Verroken1, Patrick Calders2, Inge De Wandele2, Fransiska Malfait3, Hans Zmierczak1, Stefan Goemaere1, Jean-Marc Kaufman1, Bruno Lapauw1 & Lies Rombaut2,3

26 views


1Unit for Osteoporosis and Metabolic Bone Diseases, Department of Endocrinology, Ghent University Hospital, Ghent, Belgium; 2Department of Rehabilitation Sciences and Physiotherapy, Ghent University-Artevelde University College, Ghent, Belgium; 3Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.


Background: Ehlers–Danlos syndrome (EDS) comprises a group of inherited connective tissue disorders, caused by various defects in the biosynthesis or secretion of fibrillar collagens. As collagen represents a major constituent of the bone matrix as well as of tendons and muscle, bone strength in EDS patients might be impaired both via direct and indirect pathways. Although decreased muscle strength, decreased areal bone mineral density (BMD) and increased fracture risk have been reported, no studies have investigated volumetric bone parameters in these patients.

Objective: We aimed to compare volumetric BMD (vBMD) and cortical bone geometry in patients with EDS hypermobility type (EDS-HT) and age- and sex-matched controls.

Methods: Forty-two female EDS-HT patients (mean age 40.0±10.8 years) and 42 controls were included in a cross-sectional study. vBMD and bone geometry at the tibia (4 and 66% region) as well as lower leg muscle cross-sectional area (CSA, 66% region) were measured using pQCT.

Results: Although EDS-HT patients did not differ from controls with regard to trabecular or cortical vBMD, they presented with about 6.3% smaller trabecular bone area (P=0.014), 8.9% smaller cortical bone area (P=0.005), 6.6% smaller cortical thickness (P=0.021), and, albeit non-significant, 2.9% smaller periosteal circumference (P=0.101). As a result, strength-strain index was 9.8% lower in EDS-HT patients as compared with controls (P=0.039). Furthermore, EDS-HT was associated with a 10.8% decreased muscle CSA (P=0.004) without differences in muscle density. Bone/muscle CSA ratio was within the normal range and did not differ between groups.

Conclusions: EDS-HT patients present with both a trabecular and cortical tibial bone size deficit as compared with controls, which might contribute to their increased fracture risk. As indicated by the decreased muscle CSA and normal bone/muscle CSA ratio, this bone size deficit is probably secondary to decreased mechanical loading in these patients with known muscle dysfunction.

Volume 5

43rd Annual European Calcified Tissue Society Congress

Rome, Italy
14 May 2016 - 17 May 2016

European Calcified Tissue Society 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.